Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
This study evaluated the association between serum 1,25-dihydroxyvitamin D [1,25(OH)2D] levels and ESA responsiveness in patients with pre-dialysis CKD.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Adult patients aged ≥ 19 years were eligible if they had anemia and CKD, defined as an eGFR of <60 mL/min/1.73 m2.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Association of Serum 1,25-Dihydroxyvitamin D Levels with Erythropoietin Resistance Index-Based Relative Erythropoiesis-Stimulating Agent Hyporesponsiveness in Pre-Dialysis Chronic Kidney Disease
Study design awaiting verification · International Journal of Molecular Sciences · 2026
Original publication title
Association of Serum 1,25-Dihydroxyvitamin D Levels with Erythropoietin Resistance Index-Based Relative Erythropoiesis-Stimulating Agent Hyporesponsiveness in Pre-Dialysis Chronic Kidney Disease
© 2026 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Erythropoiesis-stimulating agent (ESA) hyporesponsiveness is a major challenge in the management of anemia in chronic kidney disease (CKD). This study evaluated the association between serum 1,25-dihydroxyvitamin D [1,25(OH)2D] levels and ESA responsiveness in patients with pre-dialysis CKD. This retrospective cohort study included 363 adult patients with anemia and pre-dialysis CKD who received continuous erythropoietin receptor activator therapy for at least three months. ESA responsiveness was assessed using the erythropoietin resistance index (ERI). The highest ERI tertile was used to define ERI-based relative ESA hyporesponsiveness.
Among 363 patients, 121 (33.3%) were classified as having relative ESA hyporesponsiveness. Serum 1,25(OH)2D levels were significantly lower in the relative ESA-hyporesponsive group. In multivariable analyses, lower serum 1,25(OH)2D levels were independently associated with relative ESA hyporesponsiveness and higher log-transformed ERI. Exploratory ROC analysis showed modest discriminative ability for identifying patients in the highest ERI tertile. Lower serum 1,25(OH)2D levels were independently associated with ERI-based relative ESA hyporesponsiveness in pre-dialysis CKD. These findings suggest that active vitamin D status may be linked to ESA responsiveness, as assessed by ERI.
Authors’ abstract
Erythropoiesis-stimulating agent (ESA) hyporesponsiveness is a major challenge in the management of anemia in chronic kidney disease (CKD). This study evaluated the association between serum 1,25-dihydroxyvitamin D [1,25(OH)2D] levels and ESA responsiveness in patients with pre-dialysis CKD. This retrospective cohort study included 363 adult patients with anemia and pre-dialysis CKD who received continuous erythropoietin receptor activator therapy for at least three months. ESA responsiveness was assessed using the erythropoietin resistance index (ERI). The highest ERI tertile was used to define ERI-based relative ESA hyporesponsiveness.
Among 363 patients, 121 (33.3%) were classified as having relative ESA hyporesponsiveness. Serum 1,25(OH)2D levels were significantly lower in the relative ESA-hyporesponsive group. In multivariable analyses, lower serum 1,25(OH)2D levels were independently associated with relative ESA hyporesponsiveness and higher log-transformed ERI. Exploratory ROC analysis showed modest discriminative ability for identifying patients in the highest ERI tertile. Lower serum 1,25(OH)2D levels were independently associated with ERI-based relative ESA hyporesponsiveness in pre-dialysis CKD. These findings suggest that active vitamin D status may be linked to ESA responsiveness, as assessed by ERI.
Publication and source details
Original title: Association of Serum 1,25-Dihydroxyvitamin D Levels with Erythropoietin Resistance Index-Based Relative Erythropoiesis-Stimulating Agent Hyporesponsiveness in Pre-Dialysis Chronic Kidney Disease
Jun Yeong Kim; Dong Won Lee; Soo Bong Lee; Il Young Kim
International Journal of Molecular Sciences · 2026
* Correspondence: iykim@pusan.ac.kr© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:41:47.653143+00:00
DOI: 10.3390/ijms27188044 · PMC13607677